iCo Therapeutics Inc (CVE:ICO) shares shot up 20% on Monday . The stock traded as high as C$0.06 and last traded at C$0.06. 497,300 shares traded hands during mid-day trading, an increase of 121% from the average session volume of 225,309 shares. The stock had previously closed at C$0.05.
The company has a market cap of $4.37 million and a P/E ratio of -2.50.
COPYRIGHT VIOLATION NOTICE: “iCo Therapeutics (ICO) Stock Price Up 20%” was originally posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark & copyright law. The correct version of this news story can be accessed at https://www.baseballdailydigest.com/news/2019/02/11/ico-therapeutics-ico-stock-price-up-20.html.
iCo Therapeutics Company Profile (CVE:ICO)
iCo Therapeutics Inc, a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat sight and life threatening diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat sight threatening ocular allergies and various systemic disease indications; and Oral AmpB Delivery System that is in pre-clinical stage used for the treatment of systemic fungal infections.
Featured Story: Why is cost of goods sold important?
Receive News & Ratings for iCo Therapeutics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for iCo Therapeutics and related companies with MarketBeat.com’s FREE daily email newsletter.